Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry.

Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry.

Item
http://www.wikidata.org/entity/Q30585813
Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study.Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly.Patient-focussed outcomes in acromegaly.Attitudes and preferences in patients with acromegaly on long-term treatment with somatostatin analogues.Lanreotide autogel(®): a review of its use in the treatment of patients with acromegaly.Lanreotide autogel in acromegaly - a decade on.A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry.New therapeutic agents for acromegaly.Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center.The care continuum in acromegaly: how patients, nurses, and physicians can collaborate for successful treatment experiences.How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review.Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis.
P2860

Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry.

Item
http://www.wikidata.org/entity/Q30585813
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Lanreotide extended-release aq ...... r data from the SODA registry.
@ast
Lanreotide extended-release aq ...... r data from the SODA registry.
@en
type
label
Lanreotide extended-release aq ...... r data from the SODA registry.
@ast
Lanreotide extended-release aq ...... r data from the SODA registry.
@en
prefLabel
Lanreotide extended-release aq ...... r data from the SODA registry.
@ast
Lanreotide extended-release aq ...... r data from the SODA registry.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Lanreotide extended-release aq ...... r data from the SODA registry.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932